These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2461516)

  • 1. Suppression of the immune response by cytotoxic T cells.
    Simpson E
    Nature; 1988 Dec; 336(6198):426. PubMed ID: 2461516
    [No Abstract]   [Full Text] [Related]  

  • 2. The presentation of cell surface alloantigens to T cells.
    Owens T; Czitrom AA; Gascoigne NR; Crispe IN; Ratcliffe MJ; Lai PK; Mitchison NA
    Immunobiology; 1984 Dec; 168(3-5):189-201. PubMed ID: 6241598
    [No Abstract]   [Full Text] [Related]  

  • 3. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.
    Good MF; Powell LW; Halliday JW
    Immunology; 1989 Jun; 67(2):225-30. PubMed ID: 2568977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells.
    Acres RB; Conlon PJ; Mochizuki DY; Gallis B
    J Immunol; 1987 Oct; 139(7):2268-74. PubMed ID: 3116077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV immunization. Fresh pathways to follow.
    Bolognesi DP
    Nature; 1990 Apr; 344(6269):818-9. PubMed ID: 1691822
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
    Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
    J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
    AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory activities of autoreactive T cells: an I-A-specific T cell clone mediates both help and suppression of antibody responses.
    Clayberger C; Dekruyff RH; Cantor H
    J Immunol; 1984 May; 132(5):2237-43. PubMed ID: 6201537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the activation of cytotoxic T lymphocytes by prostaglandins and antigens.
    Ting CC; Hargrove ME
    J Immunol; 1984 Aug; 133(2):660-6. PubMed ID: 6203973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.
    Kapp JA; Honjo K; Kapp LM; Xu Xy; Cozier A; Bucy RP
    Int Immunol; 2006 Nov; 18(11):1549-62. PubMed ID: 16966495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer.
    Mukherji B; Guha A; Loomis R; Ergin MT
    J Immunol; 1987 Mar; 138(6):1987-91. PubMed ID: 2950174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
    Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
    Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
    Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
    Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes.
    Yamashita N; Clement LT
    J Immunol; 1989 Sep; 143(5):1518-23. PubMed ID: 2474603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells.
    Yano A; Aosai F; Ohta M; Hasekura H; Sugane K; Hayashi S
    J Parasitol; 1989 Jun; 75(3):411-6. PubMed ID: 2786064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of autoreactive T cells in B-cell activation.
    Finnegan A; Needleman BW; Hodes RJ
    Year Immunol; 1985; ():25-38. PubMed ID: 2953143
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice using interleukin-18-secreting fibroblasts loaded with an epitope peptide.
    Chung SW; Cohen EP; Kim TS
    Vaccine; 2004 Jun; 22(20):2547-57. PubMed ID: 15193380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.